<?xml version="1.0" encoding="UTF-8"?>
<akn:akomaNtoso xmlns:akn="http://docs.oasis-open.org/legaldocml/ns/akn/3.0"><akn:act><akn:meta><akn:identification source="#cosilico"><akn:FRBRWork prescriptive="true" authoritative="true"><akn:FRBRuri value="/akn/us/usc/25/1680q" /><akn:FRBRdate date="2025-12-31" name="retrieval" /><akn:FRBRauthor href="#us-congress" /><akn:FRBRcountry value="us" /></akn:FRBRWork><akn:FRBRExpression><akn:FRBRuri value="/akn/us/usc/25/1680q/eng@2025" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /><akn:FRBRlanguage language="en" /></akn:FRBRExpression><akn:FRBRManifestation><akn:FRBRuri value="/akn/us/usc/25/1680q/eng@2025/main.xml" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /></akn:FRBRManifestation></akn:identification></akn:meta><akn:body><akn:section eId="sec_1680q"><akn:num>1680q</akn:num><akn:heading>Prescription drug monitoring</akn:heading><akn:content><akn:p>§ 1680q. Prescription drug monitoring(a) Monitoring(1) EstablishmentThe Secretary, in coordination with the Secretary of the Interior and the Attorney General, shall establish a prescription drug monitoring program, to be carried out at health care facilities of the Service, tribal health care facilities, and urban Indian health care facilities.


(2) ReportNot later than 18 months after March 23, 2010, the Secretary shall submit to the Committee on Indian Affairs of the Senate and the Committee on Natural Resources of the House of Representatives a report that describes—(A) the needs of the Service, tribal health care facilities, and urban Indian health care facilities with respect to the prescription drug monitoring program under paragraph (1);

(B) the planned development of that program, including any relevant statutory or administrative limitations; and

(C) the means by which the program could be carried out in coordination with any State prescription drug monitoring program.



(b) Abuse(1) In generalThe Attorney General, in conjunction with the Secretary and the Secretary of the Interior, shall conduct—(A) an assessment of the capacity of, and support required by, relevant Federal and tribal agencies—(i) to carry out data collection and analysis regarding incidents of prescription drug abuse in Indian communities; and

(ii) to exchange among those agencies and Indian health programs information relating to prescription drug abuse in Indian communities, including statutory and administrative requirements and limitations relating to that abuse; and


(B) training for Indian health care providers, tribal leaders, law enforcement officers, and school officials regarding awareness and prevention of prescription drug abuse and strategies for improving agency responses to addressing prescription drug abuse in Indian communities.


(2) ReportNot later than 18 months after March 23, 2010, the Attorney General shall submit to the Committee on Indian Affairs of the Sen</akn:p></akn:content><akn:subsection eId="subsec_1680q_a"><akn:num>(a)</akn:num><akn:heading>Monitoring</akn:heading><akn:content><akn:p>(a) Monitoring</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_1680q_b"><akn:num>(b)</akn:num><akn:heading>Abuse</akn:heading><akn:content><akn:p>(b) Abuse</akn:p></akn:content></akn:subsection></akn:section></akn:body></akn:act></akn:akomaNtoso>